ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Virginia Commonwealth University
Study ID
NCT06185205
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
45 Years - 79 Years
Healthy Volunteers
Not accepted

Interventions

  • Accelerated partial breast irradiation — DRUG
    High Dose Rate treatment delivery

Study Details

The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.

Key Dates

Start date
Dec 12, 2023
Status verified
Nov 2025
Primary completion
Jan 31, 2031
Completion
Jan 31, 2033

Study Design

Enrollment
170 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Accelerated Partial Breast Irradiation (APBI)
    7.5 gray (Gy) × 3 fractions via multicatheter brachytherapy

Primary Outcome Measure

Assess the toxicity (at 1 and 3 years) of a 1.5-day APBI treatment course [ Time Frame: 1 year, and 5 years following irradiation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Virginia Commonwealth UniversityRichmondVirginia23298
Massey CTO Breast Team
[email protected]
804-628-6430
Bridget Quinn, MD, Ph.D (PRINCIPAL_INVESTIGATOR)

Find similar trials in Richmond, VA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Virginia Commonwealth University· Richmond, VA

Related Studies